Eli Lilly has launched Mounjaro, a first-of-its-kind drug for obesity and type 2 diabetes, in India. This medication, approved by CDSCO, helps with we ...

The study assesses Continuous Glucose monitors accuracy in adults with Diabetic Ketoacidosis (DKA) to improve treatment and ...

WireDaily.com has released a new Gluco Extend Reviews report for 2025. CHICAGO HEIGHTS, IL / ACCESS Newswire / March 21, 2025 / WireDaily is proud to announce the release of its Gluco Extend Reviews ...

FORGET a six-pack, do you just long for the day when you can do up your jeans without performing a gymnastics routine worthy ...

KOS AI to Host Press Conference on Argus: A Non-Invasive Blood Glucose Monitoring Breakthrough ...

Insulet unveils positive RADIANT trial clinical data for its Omnipod 5 at the 18th international conference on ATTD.

Care announced publication by The New England Journal of Medicine of results from the company’s pivotal trial of Control-IQ+ ...

"In Type 1 and Type 2 diabetes, RT-CGM lowered HbA1c, improved time spent within the target glucose range (70–180 mg/dL), and reduced episodes of hypoglycemia in T1D and hypergl ...

Insulet Corporation’s RADIANT study shows glycaemic improvements with Omnipod 5 automated insulin delivery system: Action, Massachusetts Friday, March 21, 2025, 18:00 Hrs [IST] ...

Health professionals stress that lasting weight loss is not about quick fixes but making sustainable lifestyle choices ...

The popular anti-obesity drug Mounjaro has finally been launched in India. The development comes after Eli Lilly received ...

Understanding your blood sugar levels after eating is a key part of maintaining overall health. Whether you’re managing ...